FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912308276> ?p ?o ?g. }

• W2912308276 endingPage "21" @default.
• W2912308276 startingPage "3" @default.
• W2912308276 abstract "ABSTRACT Vertebral augmentation is among the current standards of care to reduce pain in patients with vertebral fractures (VF), yet a lack of consensus regarding efficacy and safety of percutaneous vertebroplasty and kyphoplasty raises questions on what basis clinicians should choose one therapy over another. Given the lack of consensus in the field, the American Society for Bone and Mineral Research (ASBMR) leadership charged this Task Force to address key questions on the efficacy and safety of vertebral augmentation and other nonpharmacological approaches for the treatment of pain after VF. This report details the findings and recommendations of this Task Force. For patients with acutely painful VF, percutaneous vertebroplasty provides no demonstrable clinically significant benefit over placebo. Results did not differ according to duration of pain. There is also insufficient evidence to support kyphoplasty over nonsurgical management, percutaneous vertebroplasty, vertebral body stenting, or KIVA®. There is limited evidence to determine the risk of incident VF or serious adverse effects (AE) related to either percutaneous vertebroplasty or kyphoplasty. No recommendation can be made about harms, but they cannot be excluded. For patients with painful VF, it is unclear whether spinal bracing improves physical function, disability, or quality of life. Exercise may improve mobility and may reduce pain and fear of falling but does not reduce falls or fractures in individuals with VF. General and intervention‐specific research recommendations stress the need to reduce study bias and address methodological flaws in study design and data collection. This includes the need for larger sample sizes, inclusion of a placebo control, more data on serious AE, and more research on nonpharmacologic interventions. Routine use of vertebral augmentation is not supported by current evidence. When it is offered, patients should be fully informed about the evidence. Anti‐osteoporotic medications reduce the risk of subsequent vertebral fractures by 40–70%. © 2018 American Society for Bone and Mineral Research." @default.
• W2912308276 created "2019-02-21" @default.
• W2912308276 creator A5004535787 @default.
• W2912308276 creator A5014041200 @default.
• W2912308276 creator A5021940540 @default.
• W2912308276 creator A5032638450 @default.
• W2912308276 creator A5036470851 @default.
• W2912308276 creator A5040569546 @default.
• W2912308276 creator A5042414719 @default.
• W2912308276 creator A5058775754 @default.
• W2912308276 creator A5062883725 @default.
• W2912308276 creator A5064307236 @default.
• W2912308276 creator A5066827451 @default.
• W2912308276 creator A5076667369 @default.
• W2912308276 creator A5082230232 @default.
• W2912308276 creator A5087726384 @default.
• W2912308276 creator A5090296288 @default.
• W2912308276 date "2019-01-01" @default.
• W2912308276 modified "2023-09-29" @default.
• W2912308276 title "The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force Report" @default.
• W2912308276 cites W1586519452 @default.
• W2912308276 cites W1603542901 @default.
• W2912308276 cites W1839816935 @default.
• W2912308276 cites W1854311676 @default.
• W2912308276 cites W1968891536 @default.
• W2912308276 cites W1979025420 @default.
• W2912308276 cites W1982110094 @default.
• W2912308276 cites W1989292330 @default.
• W2912308276 cites W1998089330 @default.
• W2912308276 cites W1998897185 @default.
• W2912308276 cites W2007464845 @default.
• W2912308276 cites W2013098580 @default.
• W2912308276 cites W2018079465 @default.
• W2912308276 cites W2025047353 @default.
• W2912308276 cites W2031400196 @default.
• W2912308276 cites W2038954328 @default.
• W2912308276 cites W2044098433 @default.
• W2912308276 cites W2052894488 @default.
• W2912308276 cites W2053128054 @default.
• W2912308276 cites W2053796050 @default.
• W2912308276 cites W2059724197 @default.
• W2912308276 cites W2060603460 @default.
• W2912308276 cites W2072473425 @default.
• W2912308276 cites W2073852079 @default.
• W2912308276 cites W2075523932 @default.
• W2912308276 cites W2079949712 @default.
• W2912308276 cites W2085293851 @default.
• W2912308276 cites W2086582575 @default.
• W2912308276 cites W2115574045 @default.
• W2912308276 cites W2128817064 @default.
• W2912308276 cites W2129511008 @default.
• W2912308276 cites W2143000612 @default.
• W2912308276 cites W2145699511 @default.
• W2912308276 cites W2147314892 @default.
• W2912308276 cites W2155281554 @default.
• W2912308276 cites W2164184073 @default.
• W2912308276 cites W2166458965 @default.
• W2912308276 cites W2196383487 @default.
• W2912308276 cites W228024174 @default.
• W2912308276 cites W2298135821 @default.
• W2912308276 cites W2332261810 @default.
• W2912308276 cites W2332437234 @default.
• W2912308276 cites W2518383310 @default.
• W2912308276 cites W2616483165 @default.
• W2912308276 cites W2802265732 @default.
• W2912308276 cites W2982407581 @default.
• W2912308276 cites W4239569132 @default.
• W2912308276 cites W4378778821 @default.
• W2912308276 doi "https://doi.org/10.1002/jbmr.3653" @default.
• W2912308276 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30677181" @default.
• W2912308276 hasPublicationYear "2019" @default.
• W2912308276 type Work @default.
• W2912308276 sameAs 2912308276 @default.
• W2912308276 citedByCount "76" @default.
• W2912308276 countsByYear W29123082762019 @default.
• W2912308276 countsByYear W29123082762020 @default.
• W2912308276 countsByYear W29123082762021 @default.
• W2912308276 countsByYear W29123082762022 @default.
• W2912308276 countsByYear W29123082762023 @default.
• W2912308276 crossrefType "journal-article" @default.
• W2912308276 hasAuthorship W2912308276A5004535787 @default.
• W2912308276 hasAuthorship W2912308276A5014041200 @default.
• W2912308276 hasAuthorship W2912308276A5021940540 @default.
• W2912308276 hasAuthorship W2912308276A5032638450 @default.
• W2912308276 hasAuthorship W2912308276A5036470851 @default.
• W2912308276 hasAuthorship W2912308276A5040569546 @default.
• W2912308276 hasAuthorship W2912308276A5042414719 @default.
• W2912308276 hasAuthorship W2912308276A5058775754 @default.
• W2912308276 hasAuthorship W2912308276A5062883725 @default.
• W2912308276 hasAuthorship W2912308276A5064307236 @default.
• W2912308276 hasAuthorship W2912308276A5066827451 @default.
• W2912308276 hasAuthorship W2912308276A5076667369 @default.
• W2912308276 hasAuthorship W2912308276A5082230232 @default.
• W2912308276 hasAuthorship W2912308276A5087726384 @default.
• W2912308276 hasAuthorship W2912308276A5090296288 @default.
• W2912308276 hasBestOaLocation W29123082761 @default.
• W2912308276 hasConcept C126322002 @default.
• W2912308276 hasConcept C141071460 @default.

• next